Zydus Lifesciences Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
26.06 | 59.48 | -56.19% | 20.72 | +25.76% |
| P/S |
|
5.29 | 18.4 | -71.27% |
|
|
| P/BV |
|
4.55 | 8.7 | -47.67% |
|
|
| P/FCF |
|
0 | -381.81 | -100% |
|
|
| Ev/Ebitda |
|
14.65 | 4.22 | 247.52% |
|
|
| Ev/S |
|
5.31 | 14.52 | -63.46% |
|
|
| Ev/FCF |
|
43.48 | -314.48 | -113.83% |
|
|
| E/P |
|
0 | 0.0159 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
18.1 | -32.76 | -155.24% | 20.59 | -12.12% |
| ROE |
|
20.67 | 3.58 | 477.22% |
|
|
| ROA |
|
14.03 | 3.38 | 315.02% |
|
|
| ROIC |
|
0 | 11.26 | -100% |
|
|
| ROS |
|
20.29 | -47.93 | -142.34% |
|
|
| ROCE |
|
0 | -3.43 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -0.571 | -100% | 0.5167 | -100% |
| Nеt Debt/Ebitda |
|
0.1033 | -0.2949 | -135.03% |
|
|
| Debt/Ratio |
|
0 | 0.1259 | -100% |
|
|
| Debt/Equity |
|
0 | 0.3034 | -100% |
|
|
| Debt/Net Income |
|
0 | 1.67 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
1.8/10
|
0.7249 | 0.6379 | 13.63% | 1.08 | -32.71% |
| Number of years of dividend growth |
|
1 | 0.84 | 19.05% | ||
| DSI |
|
0.8571 | 0.8171 | 4.9% |
|
|
| Average dividend growth |
|
-1.94 | 0.8603 | -326.01% |
|
|
| Average percentage for 5 years |
|
1.08 | 0.8744 | 23.21% |
|
|
| Average percentage for payments |
|
19.8 | 22.22 | -10.9% |
|
|
| Difference from average difference in sector |
|
0.087 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
37.72 | 72.61 | -48.05% | ||
| Growth impulse Ebitda in 5 years |
|
36.84 | 72.97 | -49.51% | ||
| Growth impulse Net Income in 5 years |
|
228.02 | 159.06 | 43.35% | ||
| Growth impulse FCF in 5 years |
|
44.96 | 85.72 | -47.55% | ||
| Growth impulse EPS in 5 years |
|
233.73 | 36.2 | 545.66% |
IP Score
5.76/10
